MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.01.1kQ|P|2.5.1|
PID|||2A8p-A.01.01^^^AIRA-TEST^MR||Lindstrom^Lonnie^Rufus^^^^L|Edwards^Inger|20131212|M||2054-5^Black or African-American^HL70005|382 Lincoln Pl^^Camden^MI^49232^USA^P||^PRN^PH^^^517^2726554|||||||||2186-5^not Hispanic or Latino^HL70005|
PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171208|20171208|
NK1|1|Edwards^Inger^^^^^L|MTH^Mother^HL70063|382 Lincoln Pl^^Camden^MI^49232^USA^P|^PRN^PH^^^517^2726554|
ORC|RE||R44F2.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20171208||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|
RXR|SC^^HL70162|LA^^HL70163|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171208||||||F|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.02.1kV|P|2.5.1|
PID|||2A8p-A.01.02^^^AIRA-TEST^MR||Short^Peg^A^^^^L||19501210|F|
ORC|RE||A35Z3.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20171208||52^Hep A^CVX|1|mL^milliliters^UCUM||00^Administered^NIP001||||||I90FV||MSD^Merck and Co^MVX||||A|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|85^Hepatitis A^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171208||||||F|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.03.1kZ|P|2.5.1|
PID|||2A8p-A.01.03^^^AIRA-TEST^MR||Adair^Eldred^K^^^^L||20041125|M|
ORC|RE||D40U4.3^AIRA|
RXA|0|1|20151207||83^Hep A^CVX|999|||01^Historical^NIP001||||||||||||A|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.04.1l1|P|2.5.1|
PID|||2A8p-A.01.04^^^AIRA-TEST^MR||Christian^Nicky^Sammie^^^^L||20041211|M||2054-5^Black or African-American^HL70005|6 Curry Cir^^Bloomfield Township^MI^48301^USA^P||^PRN^PH^^^248^9211316|||||||||2186-5^not Hispanic or Latino^HL70005|
PD1|||||||||||02^Reminder/Recall - any method^HL70215|N||||A|20171208|20171208|
ORC|RE||S14V5.3^AIRA|
RXA|0|1|20151205||83^Hep A^CVX|999|||01^Historical^NIP001||||||||||||A|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.05.1l3|P|2.5.1|
PID|||2A8p-A.01.05^^^AIRA-TEST^MR||Johnson^Mariabella^A^^^^L||20131129|F||2054-5^Black or African-American^HL70005|269 Gabrielsen Ave^^Pittsford^MI^49271^USA^P||^PRN^PH^^^517^7328220|||||||||2135-2^Hispanic or Latino^HL70005|
ORC|RE||J43Q6.2^AIRA|
RXA|0|1|20150701||94^MMRV^CVX|999||||||||||||00^Parental Decision^NIP002||RE|A|
ORC|RE||J43Q6.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20171208||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171208||||||F|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.06.1l7|P|2.5.1|
PID|||2A8p-A.01.06^^^AIRA-TEST^MR||Crawford^Prabodh^Brahnan^^^^L||20041129|M||2054-5^Black or African-American^HL70005|299 Santa Cruz Cir^^Drummond Island^MI^49726^USA^P||^PRN^PH^^^906^7502672|||||||||2186-5^not Hispanic or Latino^HL70005|
ORC|RE||O74A7.2^AIRA|
RXA|0|1|20151202||998^No vaccine administered^CVX|999|||||||||||||||A|
OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella infection^SCT||||||F|
ORC|RE||O74A7.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20171208||118^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z3245NJ||SKB^GlaxoSmithKline^MVX||||A|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171208||||||F|
MSH|^~\&|||||20181208094705-0700||VXU^V04^VXU_V04|2A8p-A.01.07.1lc|P|2.5.1|
PID|||2A8p-A.01.07^^^AIRA-TEST^MR||Fayette^Dorian^Edsel^^^^L||20131218|M||2106-3^White^HL70005|325 Greer Pl^^East China^MI^48054^USA^P||^PRN^PH^^^810^4050008|||||||||2186-5^not Hispanic or Latino^HL70005|
ORC|RE||C42B8.1^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20141212||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|
RXR|SC^^HL70162|LA^^HL70163|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20141212||||||F|
ORC|RE||C42B8.2^AIRA|
RXA|0|1|20150706||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|
ORC|RE||C42B8.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|
RXA|0|1|20171208||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|
RXR|SC^^HL70162|LA^^HL70163|
OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171208|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|
OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|
OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|
OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171208||||||F|
